Finance
Finance
Outokumpu earnings slump, sees further decline in Q4 amid muted steel demand
Finance
Glencore reports lower copper production in first nine months
Finance
Santander UK criticises motor finance scheme as it withholds third-quarter results
Finance
Telenor slightly lags earnings forecast, takes $50 million hit in Malaysia
Chip shortage intensifies in German industry, says Ifo
Date: October 29, 2025
BERLIN (Reuters) -Shortages of materials for German manufacturers of electronic and optical products became more acute in October, driven by a tightening of global controls on rare earth components,...
Aston Martin cuts development spend as tariffs, weak China hit earnings
Date: October 29, 2025
By Raechel Thankam Job (Reuters) -Aston Martin will cut its spending on developing new cars by 300 million pounds ($402 million) after uncertainty from U.S. tariffs and "extremely subdued" Chinese...
Polish jets intercepted a Russian aircraft over Baltic Sea, army says
Date: October 29, 2025
WARSAW (Reuters) -Polish jets intercepted a Russian aircraft on Tuesday that was flying a reconnaissance mission in international airspace over the Baltic Sea without a filed flight plan and with its...
Melissa kills 25 in Haiti, nearly 30 total as hurricane batters Caribbean
Date: October 29, 2025
By Sarah Morland KINGSTON (Reuters) -Hurricane Melissa slammed into the southern coast of eastern Cuba on Wednesday, hours after causing devastation in neighboring Jamaica as the strongest-ever...
German engineering body warns US tariff expansion could hit over half of machinery exports
Date: October 29, 2025
BERLIN (Reuters) -More than half of German and European machinery exports to the United States could be hit by new tariffs if Washington expands its list in December, Germany's VDMA said on Tuesday,...
GSK cancer, HIV drug sales lift 2025 outlook in boost for shares
Date: October 29, 2025
(Reuters) -GSK raised its 2025 sales expectations on Wednesday, helped by double-digit growth in the third-quarter in its specialty medicines, including HIV and oncology. The drugmaker expects...